These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 9786487)
21. Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan. Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Furumoto A; Kobayashi S; Sato A; Nagatake T J Hosp Infect; 2001 Apr; 47(4):294-300. PubMed ID: 11289773 [TBL] [Abstract][Full Text] [Related]
22. A chromosomal location of the mupA gene in Staphylococcus aureus expressing high-level mupirocin resistance. Udo EE; Al-Sweih N; Noronha BC J Antimicrob Chemother; 2003 May; 51(5):1283-6. PubMed ID: 12668579 [TBL] [Abstract][Full Text] [Related]
23. Surveillance for mupirocin resistance among methicillin-resistant Staphylococcus aureus clinical isolates. Mongkolrattanothai K; Mankin P; Raju V; Gray B Infect Control Hosp Epidemiol; 2008 Oct; 29(10):993-4. PubMed ID: 18808349 [No Abstract] [Full Text] [Related]
24. Clonal dissemination of mupirocin-resistant staphylococci in Greek hospitals. Petinaki E; Spiliopoulou I; Kontos F; Maniati M; Bersos Z; Stakias N; Malamou-Lada H; Koutsia-Carouzou Ch; Maniatis AN J Antimicrob Chemother; 2004 Jan; 53(1):105-8. PubMed ID: 14657085 [TBL] [Abstract][Full Text] [Related]
25. The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. Schmitz FJ; Lindenlauf E; Hofmann B; Fluit AC; Verhoef J; Heinz HP; Jones ME J Antimicrob Chemother; 1998 Oct; 42(4):489-95. PubMed ID: 9818748 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis. Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864 [TBL] [Abstract][Full Text] [Related]
27. Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance. Pérez-Roth E; Claverie-Martín F; Villar J; Méndez-Alvarez S J Clin Microbiol; 2001 Nov; 39(11):4037-41. PubMed ID: 11682527 [TBL] [Abstract][Full Text] [Related]
28. A high prevalence of mupirocin and macrolide resistance determinant among Staphylococcus aureus strains isolated from burnt patients. Shahsavan S; Emaneini M; Noorazar Khoshgnab B; Khoramian B; Asadollahi P; Aligholi M; Jabalameli F; Eslampour MA; Taherikalani M Burns; 2012 May; 38(3):378-82. PubMed ID: 22040930 [TBL] [Abstract][Full Text] [Related]
29. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. Zhang K; Sparling J; Chow BL; Elsayed S; Hussain Z; Church DL; Gregson DB; Louie T; Conly JM J Clin Microbiol; 2004 Nov; 42(11):4947-55. PubMed ID: 15528678 [TBL] [Abstract][Full Text] [Related]
30. Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains. Semret M; Miller MA Infect Control Hosp Epidemiol; 2001 Sep; 22(9):578-80. PubMed ID: 11732789 [TBL] [Abstract][Full Text] [Related]
31. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Orrett FA Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397 [TBL] [Abstract][Full Text] [Related]
32. Low prevalence of mupirocin resistance among Staphylococcus aureus clinical isolates from a Chinese tertiary hospital. Chen S; Jin Y; Lin C; Hao Z; Duan J; Guo Y; Wang S; Hu L; Wang L; Yu F J Med Microbiol; 2019 Feb; 68(2):201-205. PubMed ID: 30570481 [TBL] [Abstract][Full Text] [Related]
34. Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism. Driscoll DG; Young CL; Ochsner UA Antimicrob Agents Chemother; 2007 Jun; 51(6):2247-8. PubMed ID: 17438053 [TBL] [Abstract][Full Text] [Related]
35. Mupirocin resistance in methicillin-resistant Staphylococcus aureus from a veterans hospital. Naguib MH; Naguib MT; Flournoy DJ Chemotherapy; 1993; 39(6):400-4. PubMed ID: 8222867 [TBL] [Abstract][Full Text] [Related]
36. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. LaPlante KL Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452 [TBL] [Abstract][Full Text] [Related]
37. Characterization of mupirocin-resistant Staphylococcus aureus from different geographic areas. Ramsey MA; Bradley SF; Kauffman CA; Morton TM; Patterson JE; Reagan DR Antimicrob Agents Chemother; 1998 May; 42(5):1305. PubMed ID: 9593176 [No Abstract] [Full Text] [Related]
38. Low concentrations of mupirocin in the pharynx following intranasal application may contribute to mupirocin resistance in methicillin-resistant Staphylococcus aureus. Watanabe H; Masaki H; Asoh N; Watanabe K; Oishi K; Kobayashi S; Sato A; Sugita R; Nagatake T J Clin Microbiol; 2001 Oct; 39(10):3775-7. PubMed ID: 11574616 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo evaluations of the activities of lauric acid monoester formulations against Staphylococcus aureus. Rouse MS; Rotger M; Piper KE; Steckelberg JM; Scholz M; Andrews J; Patel R Antimicrob Agents Chemother; 2005 Aug; 49(8):3187-91. PubMed ID: 16048923 [TBL] [Abstract][Full Text] [Related]
40. How resistant is Staphylococcus aureus to the topical antibiotic mupirocin? Rakshit T; Shenoy M S J Glob Antimicrob Resist; 2017 Mar; 8():102-103. PubMed ID: 28082145 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]